• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH LACTATE DEHYDROGENASE (LDH); NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH LACTATE DEHYDROGENASE (LDH); NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE Back to Search Results
Model Number 2P56-22
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/13/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(6).There was no additional patient information provided by the customer due to privacy issues.A review of tickets determined that there is not an increase in complaint activity for ldh reagent lot 02747un20.Trending review determined no trends for falsely elevated results for the product.Return testing was not completed as returns were not available.File sample testing was not performed as the original sample generated correct results upon retesting.Quality control has been in range at the time of the incident.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the lactate dehydrogenase (ldh) reagent, lot number 02747un20, was identified.
 
Event Description
The customer reported falsely elevated lactate dehydrogenase (ldh) results on one patient generated on the architect analyzer.The results provided were: on (b)(6) 2021 (b)(6) initial = 1563.0u/l (normal range 125-220u/l) / retest = 147 and 148u/l.There was no reported impact to patient management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LACTATE DEHYDROGENASE (LDH)
Type of Device
NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key11215775
MDR Text Key256683096
Report Number3002809144-2021-00047
Device Sequence Number1
Product Code CFJ
UDI-Device Identifier00380740161460
UDI-Public00380740161460
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/16/2021
Device Model Number2P56-22
Device Catalogue Number02P56-22
Device Lot Number02747UN20
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/13/2021
Initial Date FDA Received01/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/03/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-